HONG KONG, March 16, 2016 (Antara/PRNewswire) -- Prenetics, a precision
medicine life sciences company focused on personalized, predictive and
preventive treatments announced a US$10 Million
Series A strategic investment led by Ping An Ventures, the venture
capital arm of Ping An Insurance Group, one of the largest insurance
companies in China and in the World. Other investors include Indonesia's
Lippo Group backed Venturra Capital, Capital Union Investments and
existing investors 500 Startups, COENT Venture Partners.
Prenetics' proprietary iGenes test helps physicians prescribe medications and dosages to achieve the most effective results with the least side effects, based on a patient's unique genetic profile.
Ping An Ventures Managing Director Jiang Zhang stated, "We believe precision medicine is the future of healthcare, primed to happen now. Prenetics has built an amazing team with a world-class scientific, medical and commercial team. We are excited to integrate Prenetics innovative DNA tests to help our 200 million customers live longer, healthier lives while saving substantial healthcare costs."
"The strategic investment by Ping An and Venturra is a huge win for us." said Danny Yeung, CEO of Prenetics. "Our goal is simple: reduce adverse drug reactions, saving lives and reducing the cost of healthcare. Over the coming months, we'll be bringing new products and services out that will continue to shape the future of healthcare and the US$213 Billion market."
Managing Partner of Venturra Capital, Rudy Ramway stated, "Prenetics is a game-changer and we are working closely to bring precision medicine to Indonesia and across Southeast Asia."
About Ping An Ventures
Ping An Ventures is a professional VC firm under Ping An Insurance (Group) Company of China, with focused interest in startups of emerging innovation. It is committed to helping its portfolio companies grow and succeed in the China market by providing not only funding but also managerial advice, introductions to Chinese key opinion leaders and partners, and other needed resources.
About Venturra Capital
Venturra Capital is a Southeast Asia focused venture capital firm investing in early and growth stage consumer technology-enabled companies. Venturra's mission is to provide capital, operational empowerment, and market access to founders of innovative, industry-transforming, technology-enabled businesses.
About PreneticsTM
For more information, visit http://prenetics.com
Media Inquiries:
Colleen Wong
Tel: +852-2210-9585
Email: colleen@prenetics.com
Prenetics' proprietary iGenes test helps physicians prescribe medications and dosages to achieve the most effective results with the least side effects, based on a patient's unique genetic profile.
Ping An Ventures Managing Director Jiang Zhang stated, "We believe precision medicine is the future of healthcare, primed to happen now. Prenetics has built an amazing team with a world-class scientific, medical and commercial team. We are excited to integrate Prenetics innovative DNA tests to help our 200 million customers live longer, healthier lives while saving substantial healthcare costs."
"The strategic investment by Ping An and Venturra is a huge win for us." said Danny Yeung, CEO of Prenetics. "Our goal is simple: reduce adverse drug reactions, saving lives and reducing the cost of healthcare. Over the coming months, we'll be bringing new products and services out that will continue to shape the future of healthcare and the US$213 Billion market."
Managing Partner of Venturra Capital, Rudy Ramway stated, "Prenetics is a game-changer and we are working closely to bring precision medicine to Indonesia and across Southeast Asia."
About Ping An Ventures
Ping An Ventures is a professional VC firm under Ping An Insurance (Group) Company of China, with focused interest in startups of emerging innovation. It is committed to helping its portfolio companies grow and succeed in the China market by providing not only funding but also managerial advice, introductions to Chinese key opinion leaders and partners, and other needed resources.
About Venturra Capital
Venturra Capital is a Southeast Asia focused venture capital firm investing in early and growth stage consumer technology-enabled companies. Venturra's mission is to provide capital, operational empowerment, and market access to founders of innovative, industry-transforming, technology-enabled businesses.
About PreneticsTM
For more information, visit http://prenetics.com
Media Inquiries:
Colleen Wong
Tel: +852-2210-9585
Email: colleen@prenetics.com
Reporter: PR Wire
Editor: PR Wire
Copyright © ANTARA 2016
